Document is current
Any future updates will be listed below
-
Authors
Sookoian, Silvia https://orcid.org/0000-0001-5929-5470
Pirola, Carlos J. https://orcid.org/0000-0001-8234-4058
Sanyal, Arun J. https://orcid.org/0000-0001-8682-5748
- License Information
-
More Information
Article History
First Online: 4 February 2025
Competing interests
: A.J.S. has served as a consultant to 89Bio, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead, Eli Lilly, Histoindex, Janssen, Lipocine, Madrigal, Merck, Glaxo-Smith Kline, Novartis, Akero, Novo Nordisk, Path AI, Histoindex, Pfizer, Poxel, Salix, Myovant, Sequana, Surrozen, Takeda, Terns and Zydus; his institution has received grant support from AstraZeneca, Bristol-Myers Squibb, Gilead, Intercept, Mallinckrodt, Merck, Ocelot and Salix; he receives royalties from Elsevier and UpToDate and has stock options in Durect, Genfit, Tiziana and Inversago. S.S. and C.J.P. declare no competing interests.
